Vandetanib for the Treatment of Symptomatic or Progressive Medullary Thyroid Cancer in Patients with Unresectable Locally Advanced or Metastatic Disease: U.S. Food and Drug Administration Drug Approval SummaryKatherine A. Thornton, Richard Pazdur, Pengfei Song et al.|Clinical Cancer Research|2012Cited by 149
Abiraterone Acetate in Combination with Prednisone for the Treatment of Patients with Metastatic Castration-Resistant Prostate Cancer: U.S. Food and Drug Administration Drug Approval SummaryPaul G. Kluetz, Richard Pazdur, Yang‐Min Ning et al.|Clinical Cancer Research|2013Cited by 62
Modeling Approaches to Reimagine Stability (MARS) for Enabling Earlier Access to Critical Drugs for Patients with Unmet Medical NeedsM. Scott Furness, Meiyu Shen, Hong Cai et al.|AAPS PharmSciTech|2023Cited by 15